600351.SS
600351.SS
CNE000001CM5
YABAO PHARMACEUTICAL GROUP CO L
Loading chart...

Valuation & History

Quarterly trend of key valuation metrics

Metric
Current (TTM) TTM Baseline
Q2 '26 30.06.2026
Q1 '26 31.03.2026
Q4 '25 31.12.2025
Market & Enterprise Value
Market Cap
4.89B EUR
3.98B EUR
4.62B EUR
4.49B EUR
Enterprise Value
3.95B EUR
3.1B EUR
3.79B EUR
3.71B EUR
Valuation Multiples
Trailing P/E
15.37x
14.08x
16.56x
16.08x
Forward P/E
--
--
--
--
Price to Sales
2.18x
2.37x
2.83x
2.69x
Price to Book
1.73x
1.41x
1.62x
1.56x
EV/Revenue
1.76x
1.85x
2.33x
2.22x
EV/EBITDA
8.49x
8.36x
11.1x
10.95x
Price to FCF (P/FCF)
10.58x
8.95x
10.23x
11.14x
EV/FCF
8.54x
6.96x
8.4x
9.19x
FCF Yield
9.45%
11.18%
9.78%
8.98%
ende